PROCEPT BioRobotics Corporation – NASDAQ:PRCT
PROCEPT BioRobotics stock price today
$39.57
-42.44
-51.75%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
PROCEPT BioRobotics stock price monthly change
+18.25%
month
PROCEPT BioRobotics stock price quarterly change
+18.25%
quarter
PROCEPT BioRobotics stock price yearly change
+90.77%
year
PROCEPT BioRobotics key metrics
Market Cap | 4.37B |
Enterprise value | 1.42B |
P/E | -17.48 |
EV/Sales | 19.05 |
EV/EBITDA | -18.05 |
Price/Sales | 21.00 |
Price/Book | 7.99 |
PEG ratio | 1.75 |
EPS | -2.12 |
Revenue | 156.32M |
EBITDA | -104.63M |
Income | -103.36M |
Revenue Q/Q | 82.50% |
Revenue Y/Y | 83.43% |
Profit margin | -116.18% |
Oper. margin | -107.61% |
Gross margin | 49.44% |
EBIT margin | -107.61% |
EBITDA margin | -66.93% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePROCEPT BioRobotics stock price history
PROCEPT BioRobotics stock forecast
PROCEPT BioRobotics financial statements
Average Price Target
$101.67
Potential upside: 156.92%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 33.10M | -25.28M | -76.38% |
|---|---|---|---|
| Sep 2023 | 35.10M | -24.62M | -70.14% |
| Dec 2023 | 43.58M | -27.50M | -63.11% |
| Mar 2024 | 44.53M | -25.95M | -58.28% |
| Jun 2023 | 272446000 | 116.54M | 42.78% |
|---|---|---|---|
| Sep 2023 | 421125000 | 121.76M | 28.92% |
| Dec 2023 | 404717000 | 123.96M | 30.63% |
| Mar 2024 | 382900000 | 118.85M | 31.04% |
| Jun 2023 | -28.33M | -5.37M | 2.43M |
|---|---|---|---|
| Sep 2023 | -18.94M | -5.78M | 162.11M |
| Dec 2023 | -24.79M | -8.71M | 2.86M |
| Mar 2024 | -32.28M | -1.94M | 2.58M |
PROCEPT BioRobotics alternative data
| Aug 2023 | 428 |
|---|---|
| Sep 2023 | 428 |
| Oct 2023 | 428 |
| Nov 2023 | 428 |
| Dec 2023 | 428 |
| Jan 2024 | 428 |
| Feb 2024 | 428 |
| Apr 2024 | 626 |
| May 2024 | 626 |
| Jun 2024 | 626 |
| Jul 2024 | 626 |
PROCEPT BioRobotics other data
31.44%
-40.72%
of PRCT is owned by hedge funds
66
-47
13.96M
-18.25M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 33310 |
| Feb 2024 | 0 | 71930 |
| Mar 2024 | 0 | 44222 |
| May 2024 | 0 | 50432 |
| Jun 2024 | 0 | 36046 |
| Sep 2024 | 0 | 247222 |
| Oct 2024 | 0 | 313461 |
| Nov 2024 | 0 | 179260 |
| Dec 2024 | 0 | 54515 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | ZADNO REZA director, officer.. | Common Stock | 5,300 | $96.15 | $509,611 | ||
Sale | ZADNO REZA director, officer.. | Common Stock | 13,762 | $97.01 | $1,335,065 | ||
Sale | ZADNO REZA director, officer.. | Common Stock | 5,126 | $98.09 | $502,809 | ||
Sale | ZADNO REZA director, officer.. | Common Stock | 2,235 | $99.04 | $221,359 | ||
Option | NOURI ALALEH officer: EVP, CLO, CORP. SEC. | Common Stock | 12,092 | $37.02 | $447,646 | ||
Sale | NOURI ALALEH officer: EVP, CLO, CORP. SEC. | Common Stock | 3,787 | $96.12 | $364,006 | ||
Option | NOURI ALALEH officer: EVP, CLO, CORP. SEC. | Common Stock | 4,162 | $34.99 | $145,628 | ||
Option | NOURI ALALEH officer: EVP, CLO, CORP. SEC. | Common Stock | 11,838 | $7.27 | $86,062 | ||
Sale | NOURI ALALEH officer: EVP, CLO, CORP. SEC. | Common Stock | 16,187 | $96.98 | $1,569,815 | ||
Sale | NOURI ALALEH officer: EVP, CLO, CORP. SEC. | Common Stock | 8,118 | $97.9 | $794,752 |
| Quarter | Transcript |
|---|---|
| Q1 2024 1 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 28 Jul 2023 | Q2 2023 Earnings Call Transcript |
Procept BioRobotics: Adding Value Through Robust Unit Economics, Reiterate Buy
EDAP: Reiterate Buy After Multiple Investment Updates
Procept BioRobotics: Adding For 2023 Rebound
Procept BioRobotics: Positioning Into FY22 Earnings (Technical Analysis)
Procept BioRobotics: Aquablation System Meaningful Insulator
MDA Breakout Stocks Week 36 - September 2022: Short-Term Picks To Give You An Edge
Procept BioRobotics Has Resources To Ramp Up Commercialization
Procept: Leveraging A Novel Water-Based System For Enlarged Prostate Treatment
U.S. IPO Weekly Recap: The Fall IPO Market Is In Full Swing With An 11 IPO Week
-
What's the price of PROCEPT BioRobotics stock today?
One share of PROCEPT BioRobotics stock can currently be purchased for approximately $39.57.
-
When is PROCEPT BioRobotics's next earnings date?
Unfortunately, PROCEPT BioRobotics's (PRCT) next earnings date is currently unknown.
-
Does PROCEPT BioRobotics pay dividends?
No, PROCEPT BioRobotics does not pay dividends.
-
How much money does PROCEPT BioRobotics make?
PROCEPT BioRobotics has a market capitalization of 4.37B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 81.55% to 136.19M US dollars.
-
What is PROCEPT BioRobotics's stock symbol?
PROCEPT BioRobotics Corporation is traded on the NASDAQ under the ticker symbol "PRCT".
-
What is PROCEPT BioRobotics's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of PROCEPT BioRobotics?
Shares of PROCEPT BioRobotics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PROCEPT BioRobotics's key executives?
PROCEPT BioRobotics's management team includes the following people:
- Dr. Reza Zadno Ph.D. Pres, Chief Executive Officer & Director(age: 70, pay: $652,800)
- Mr. Kevin Waters Senior Vice President & Chief Financial Officer(age: 48, pay: $565,380)
- Mr. Hisham Shiblaq Senior Vice President of Global Commercialization(age: 50, pay: $450,230)
-
How many employees does PROCEPT BioRobotics have?
As Jul 2024, PROCEPT BioRobotics employs 626 workers.
-
When PROCEPT BioRobotics went public?
PROCEPT BioRobotics Corporation is publicly traded company for more then 4 years since IPO on 15 Sep 2021.
-
What is PROCEPT BioRobotics's official website?
The official website for PROCEPT BioRobotics is procept-biorobotics.com.
-
Where are PROCEPT BioRobotics's headquarters?
PROCEPT BioRobotics is headquartered at 900 Island Drive, Redwood City, CA.
-
How can i contact PROCEPT BioRobotics?
PROCEPT BioRobotics's mailing address is 900 Island Drive, Redwood City, CA and company can be reached via phone at +65 02327200.
-
What is PROCEPT BioRobotics stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for PROCEPT BioRobotics in the last 12 months, the avarage price target is $101.67. The average price target represents a 156.92% change from the last price of $39.57.
PROCEPT BioRobotics company profile:
PROCEPT BioRobotics Corporation
procept-biorobotics.comExchange:
NASDAQ
Full time employees:
626
Industry:
Medical - Devices
Sector:
Healthcare
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
900 Island Drive
Redwood City, CA 94065
Redwood City, CA 94065
CIK: 0001588978
ISIN: US74276L1052
CUSIP: 74276L105
